Cytosorbents Corporation is a publicly traded company (NasdaqCM: CTSO) located in Monmouth Junction, New Jersey. Cytosorbents has created a blood purification technology based on biocompatible, porous polymer beads that act like sponges in an attempt to remove harmful substances from the blood.CytoSorb, the company's first product to market, received its CE mark approval in 2011.CytoSorbents was awarded a $3.8 million contract by Defense Advanced Research Projects Agency (DARPA) for its “Dialysis-Like Therapeutics” program to treat sepsis by removing cytokines and pathogen-derived toxins.
UpGuard's Cyber Security Ratings range from 0 to 950. The higher the score, the more likely CytoSorbents is implementing good security practices.
Read more about the latest issues in cybersecurity
Common Vulnerabilities and Exposures (CVE) is a list of publicly disclosed information security ...
Data is rapidly becoming one of the most valuable assets in the modern world. The digital giants ...
Compare CytoSorbents's security performance with other companies